Filing Details

Accession Number:
0001104659-21-075779
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-02 16:31:34
Reporting Period:
2021-05-28
Accepted Time:
2021-06-02 16:31:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1722964 Y-Mabs Therapeutics Inc. YMAB Pharmaceutical Preparations (2834) 474619612
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753193 Aps Biotech Wg Rungsted Strandvej 113
Rungsted Kyst G7 2960
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-28 25,000 $36.34 4,453,465 No 4 S Direct
Common Stock Disposition 2021-06-01 6,864 $35.57 4,446,601 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $35.69 to $37.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $35.50 to $35.96. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.